- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €331.9m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.78
7D
3.4%
1Y
-35.8%
MPH Health Care
Market Cap: €102.3m
An investment company, engages in the healthcare business in Germany.
93M1
€23.90
7D
-1.6%
1Y
27.1%
Novogenia
Market Cap: €78.0m
Manufactures and sells personalized health products in global markets.
7V0
€6.70
7D
-5.0%
1Y
-8.2%
Cantourage Group
Market Cap: €69.1m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.54
7D
-1.1%
1Y
31.9%